These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23384501)

  • 41. The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.
    Zhang LQ; Jiang F; Xu L; Wang J; Bai JL; Yin R; Wu YQ; Meng LJ
    Clin Lung Cancer; 2012 May; 13(3):188-95. PubMed ID: 22133292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
    Chen E; Zeng Z; Bai B; Zhu J; Song Z
    Oncotarget; 2016 Aug; 7(35):56526-56539. PubMed ID: 27489355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.
    Wang J; Li K; Wang B; Bi J
    Mol Biol Rep; 2012 May; 39(5):5331-8. PubMed ID: 22167333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter.
    Tian S; Wang C; An MW
    Biol Direct; 2015 Apr; 10():15. PubMed ID: 25887039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis.
    Su Y; Chen R; Han Z; Xu R; Ma L; Wufuli R; Liu H; Wang F; Ma L; Chen R; Liu J
    Pathobiology; 2021; 88(4):267-276. PubMed ID: 34107476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.
    Martin B; Paesmans M; Berghmans T; Branle F; Ghisdal L; Mascaux C; Meert AP; Steels E; Vallot F; Verdebout JM; Lafitte JJ; Sculier JP
    Br J Cancer; 2003 Jul; 89(1):55-64. PubMed ID: 12838300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.
    Jin Y; Sun Y; Shi X; Zhao J; Shi L; Yu X
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C160-6. PubMed ID: 25450276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Li W; Tse LA; Wang F
    Steroids; 2015 Dec; 104():129-36. PubMed ID: 26456481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
    Li M; Ma G; Li X; Zhou Q
    Med Sci Monit; 2022 Jul; 28():e936898. PubMed ID: 35891604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhan P; Qian Q; Yu LK
    J Thorac Dis; 2013 Feb; 5(1):40-7. PubMed ID: 23372950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
    Berghmans T; Paesmans M; Mascaux C; Martin B; Meert AP; Haller A; Lafitte JJ; Sculier JP
    Ann Oncol; 2006 Nov; 17(11):1673-6. PubMed ID: 16980598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis.
    Wang T; Zhou C; Zhou Q
    Sci Rep; 2017 May; 7(1):1527. PubMed ID: 28484235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis.
    Yang B; Jia L; Guo Q; Ren H; Hu Y; Xie T
    Oncotarget; 2016 Jul; 7(30):47265-47277. PubMed ID: 27323811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear survivin expression is associated with a poor prognosis in Caucasian non-small cell lung cancer patients.
    Xie YL; An L; Jiang H; Wang J
    Clin Chim Acta; 2012 Dec; 414():41-3. PubMed ID: 22981350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.
    Martin B; Paesmans M; Mascaux C; Berghmans T; Lothaire P; Meert AP; Lafitte JJ; Sculier JP
    Br J Cancer; 2004 Dec; 91(12):2018-25. PubMed ID: 15545971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemistry and clinical value of sirtuin 2 in non-metastasized non-small cell lung cancer.
    Gao CX; Chen B; Xie HK; Han CN; Luo J
    J Thorac Dis; 2019 Sep; 11(9):3973-3979. PubMed ID: 31656671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of prognostic profiles in non-small cell lung cancer: too many variables but a few relevant.
    Gomez de la Cámara A; López-Encuentra A; Ferrando P;
    Eur J Epidemiol; 2005; 20(11):907-14. PubMed ID: 16284868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.
    Zang X; Chen M; Zhou Y; Xiao G; Xie Y; Wang X
    Cancer Inform; 2015; 14(Suppl 2):183-91. PubMed ID: 26052221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decision analysis in NSCLC.
    Macbeth F
    Thorax; 2002 Oct; 57(10):919-20; author reply 920. PubMed ID: 12324684
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of subtype-specific prognostic signatures using Cox models with redundant gene elimination.
    Tian S
    Oncol Lett; 2018 Jun; 15(6):8545-8555. PubMed ID: 29805591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.